PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A meta-analysis of 19 studies comprising 3,003 patients

Thrombosis and Haemostasis

Volumn 99, Issue 6, 2008, Pages 1129-1131

  Crescente, Marilena ^a   Di Castelnuovo, Augusto ^a   Iacoviello, Licia ^a   De Gaetano, Giovanni ^a   Cerletti, Chiara ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b John Paul II Center for High Technology Research and Education in Biomedical Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANALYZER; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; HUMAN; LETTER; META ANALYSIS; PLATELET FUNCTION ANALYZER 100; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; CARDIOVASCULAR DISEASES; DRUG RESISTANCE; HUMANS; ODDS RATIO; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 44949172436     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-03-0130     Document Type: Letter

References (5)

1. Crescente M, Di Castelnuovo A, Iacoviello L, et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008; 99: 14-26.
2. Reny JL, de Moerloose P, Dauzat M, et al. Use of the PFA-100 trade mark closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 444-450.
3. Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. Br Med J 2008; 336: 195-198.
4. Snoep JD, Hovens MM, Eikenboom JC, et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593-1599.
5. Di Castelnuovo A, Soccio M, Iacoviello L, et al. "The C242 T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and meta-analyses. Thromb Haemost 2008, 99: 594-601.